دورية أكاديمية
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
| العنوان: | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial |
|---|---|
| المؤلفون: | Adamo, BarbaraAff1, Aff2, Bellet, MeritxellAff3, Aff4, Paré, LaiaAff2, Aff4, Pascual, TomásAff1, Aff2, Aff4, Vidal, MariaAff1, Aff2, Pérez Fidalgo, José A.Aff5, Blanch, SalvadorAff6, Martinez, NoeliaAff7, Murillo, LauraAff8, Gómez-Pardo, PatriciaAff3, López-González, AnaAff9, Amillano, KepaAff10, Canes, JordiAff4, Galván, PatriciaAff1, González-Farré, BlancaAff1, González, XavierAff4, Villagrasa, PatriciaAff4, Ciruelos, EvaAff11, Prat, AleixAff1, Aff2, Aff4 |
| المصدر: | Breast Cancer Research. 21(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1465542X |
|---|---|
| DOI: | 10.1186/s13058-019-1195-z |